paeonol has been researched along with Osteogenic Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, W; Liu, Q; Liu, S; Liu, Z; Qian, R; Zhou, J | 1 |
1 other study(ies) available for paeonol and Osteogenic Sarcoma
| Article | Year |
|---|---|
Paeonol antagonizes oncogenesis of osteosarcoma by inhibiting the function of TLR4/MAPK/NF-κB pathway.
Topics: Acetophenones; Bone Neoplasms; Carcinogenesis; Cell Line, Tumor; Humans; MAP Kinase Signaling System; Neoplasm Proteins; NF-kappa B; Osteosarcoma; Toll-Like Receptor 4 | 2020 |